Page 597 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 597

CHAPTER 32  Drugs of Abuse     583




                                                                         Opioids

                                                                          MOR

                                                                          GABA
                                                    Ca 2+                                            K +
                                    DA          VGCC                                            Kir3
                                                                 MOR
                                                                                 MOR
                                           GABA  Ca 2+      βγ                            βγ





                                                                              THC
                                                                              CB R
                                                                                1
                                                                        GABA
                                                                          A
                                            DA                        GABA R
                                                                                          GHB

                                                                                         GABA B
                                                              DA
                                                                                          GABA



                    FIGURE 32–3  Disinhibition of dopamine (DA) neurons in the ventral tegmental area (VTA) through drugs that act via G io -coupled receptors.
                    Top: Opioids target μ-opioid receptors (MORs) that in the VTA are located exclusively on γ-aminobutyric acid (GABA) neurons. MORs are expressed
                    on the presynaptic terminal of these cells and the somatodendritic compartment of the postsynaptic cells. Each compartment has distinct effectors
                    (insets). G protein-βγ-mediated inhibition of voltage-gated calcium channels (VGCC) is the major mechanism in the presynaptic terminal. Conversely,
                    in dendrites MORs activate K channels. Together the pre- and postsynaptic mechanisms reduce transmitter release and suppress activity, ultimately
                                                            9
                    taking away the inhibition by the GABA neurons. Middle: Δ -tetrahydrocannabinol (THC) and other cannabinoids mainly act through presynaptic inhi-
                    bition. Bottom: Gamma-hydroxybutyric acid (GHB) targets GABA B  receptors, which are located on both cell types. However, GABA neurons are more
                    sensitive to GHB than are DA neurons, leading to disinhibition at concentrations typically obtained with recreational use. CB 1 R, cannabinoid receptors.


                    studies show that these drugs also fail to stimulate dopamine   G  type and generates inositol trisphosphate (IP ), leading to a
                                                                          q
                                                                                                              3
                    release, further supporting the idea that only drugs that activate   release of intracellular calcium. Although hallucinogens, and LSD
                    the  mesolimbic  dopamine  system  are  addictive.  Instead,  hal-  in particular, have been proposed for several therapeutic indica-
                    lucinogens  increase  glutamate  release  in  the  cortex,  presumably   tions, efficacy has never been demonstrated.
                    by enhancing excitatory afferent input via presynaptic serotonin
                                     ) from the thalamus.
                    receptors (eg, 5-HT 2A                               DRUGS THAT MEDIATE THEIR
                       LSD is an ergot alkaloid. After synthesis, blotter paper or sugar
                    cubes are sprinkled with the liquid and allowed to dry. When LSD   EFFECTS VIA IONOTROPIC
                    is swallowed, psychoactive effects typically appear after 30 minutes   RECEPTORS
                    and last 6–12 hours. During this time, subjects have impaired
                    ability  to  make  rational  judgments  and  understand  common   NICOTINE
                    dangers, which puts them at risk for accidents and personal injury.
                       In an adult, a typical dose is 20–30 mcg. LSD is not con-  In terms of numbers affected, addiction to nicotine exceeds all
                    sidered neurotoxic, but like most ergot alkaloids, it may lead to   other forms of addiction, affecting more than 50% of all adults
                    strong contractions of the uterus that can induce abortion (see   in some countries. Nicotine exposure occurs primarily through
                    Chapter 16).                                         smoking of tobacco, which causes associated diseases that are
                       The main molecular target of LSD and other hallucinogens is   responsible for many preventable deaths. The chronic use of chew-
                    the 5-HT  receptor. This receptor couples to G proteins of the   ing tobacco and snuff tobacco is also addictive.
                            2A
   592   593   594   595   596   597   598   599   600   601   602